← return to the list of all guides

Guide sequence: ACAGCGGGGTGAGCGCGGCC CGG

Contents:

Cloning and expression of guide RNA

T7 in vitro expression from a plasmid

To produce guide RNA by in vitro transcription with T7 RNA polymerase, the guide RNA sequence can be cloned into a variety of plasmids (see AddGene website).
For the guide sequence ACAGCGGGGTGAGCGCGGCC, the following primers should be ordered for cloning into the BsaI-digested plasmid DR274 generated by the Joung lab.

NamePrimer Sequence
guideRna109rvT7sense TAGGACAGCGGGGTGAGCGCGGCC
guideRna109rvT7antisense AAACGGCCGCGCTCACCCCGCTGT

T7 in vitro expression from overlapping oligonucleotides

For spCas9, template for in vitro synthesis of guide RNA with T7 RNA polymerase can be prepared by annealing and primer extension of the following primers:

NamePrimer Sequence
guideRNA109rvT7crTarget GAAATTAATACGACTCACTATAGACAGCGGGGTGAGCGCGGCCGTTTTAGAGCTAGAAATAGCAAG
guideRNAallT7common (constant primer used for all guide RNAs) AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC
T7 RNA polymerase starts transcription most efficiently if the first two nucleotides to be transcribed are GG. A common recommendation is to add the prefix GG- if our guide does not start with G (5'-N20-(NGG)-3'), to add G- if your guide starts with a single G (5'-GN19-(NGG)-3') and to not add anything if your guide starts with GG already (5'-GGN18-(NGG)-3').

One protocol for template preparation from oligonucleotides and in-vitro transcription can be found in Bassett et al. Cell Rep 2013. We also provide our own optimized protocol for T7 guide expression.

Gagnon et al. PLoS ONE 2014 prefixed guides with GG to ensure high efficiency in vitro transcription by T7 RNA polymerase. It has been shown by other authors that the 5' nucleotides of the guide have little or no role in target specificity and it is therefore generally accepted that prefixing guides with GG should not affect activity.
However, in our lab, we found that in vitro transcription with T7 RNA polymerase is efficient enough when the sequence starts with a single G rather than with GG. This took some optimization of the reaction conditions including using large amounts of template DNA and running reactions overnight. Click here to download our optimized protocol for T7 guide expression.
Do not use G-prefixing with high-fidelity Cas9 Variants like HF1 and eSpCas9 1.1 when this adds a mismatch in the genome as the efficiency will most likely be very low.

T7 in vitro expression with the GeneArt kit

Use these two primers for the Invitrogen GeneArt kit:

NamePrimer Sequence
guideRNA109rvGeneArtFw TACGACTCACTATAGACAGCGGGGTGAGCGCGGCC
guideRNA109rvGeneArtRev TTCTAGCTCTAAAACGGCCGCGCTCACCCCGCTGT

U6 expression from an Addgene plasmid

The guide sequence ACAGCGGGGTGAGCGCGGCC does not contain the motif TTTT, which terminates RNA polymerase, so it can be transcribed in mammalian cells.

Select your Addgene plasmid:

To clone the guide into MLM3636 (Joung lab), use these primers:

Note: Efficient transcription from the U6 promoter requires a 5' G. This is not the case for this guide. Several options are possible, you can either add an additional G- prefix to the N20 guide sequence, called gN20 guides here, or replace the first with a G and create a gN19 guide. For users of HF1 and eSpCas9: G- prefixing with the high-fidelity variants may reduce efficiency, as it introduces a mismatch.

Primers for gN20 guides:
NamePrimer Sequence
gN20-guideRNA109rvU6senseMLM3636 ACACCGACAGCGGGGTGAGCGCGGCCG
gN20-guideRNA109rvU6antisenseMLM3636 AAAACGGCCGCGCTCACCCCGCTGTCG

Primers for gN19 guides:
Kim et al 2020. showed that changing the first nucleotide to 'G' is slightly more efficient.

NamePrimer Sequence
gN19-gN20-guideRNA109rvU6senseMLM3636 ACACCGCAGCGGGGTGAGCGCGGCCG
gN19-gN20-guideRNA109rvU6antisenseMLM3636 AAAACGGCCGCGCTCACCCCGCTGCG

The plasmid has to be digested with: BsmBI
Click here to download the cloning protocol for MLM3636 (Joung lab)

Lentiviral vectors: cloning with Gibson assembly

Order the following oligonucleotide to clone with Gibson assembly into the vector pLentiGuide-puro. See the protocol by Matt Canver.
To clone with restriction enzymes into this vector, see the section U6 expression from an AddGene plasmid and choose pLentiGuide-puro from the list of AddGene plasmids.
If you use lentiviral vectors, you may be interested in our tools for saturating mutagenesis and for gene knockout libraries.
NameOligonucleotide Sequence
batchOligo109rv GGAAAGGACGAAACACCGACAGCGGGGTGAGCGCGGCCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC

Summary of main cloning/expression primers

guideRNA109rvGeneArtFw TACGACTCACTATAGACAGCGGGGTGAGCGCGGCC
guideRNA109rvGeneArtRev TTCTAGCTCTAAAACGGCCGCGCTCACCCCGCTGT
gN20-guideRNA109rvU6senseMLM3636 ACACCGACAGCGGGGTGAGCGCGGCCG
gN20-guideRNA109rvU6antisenseMLM3636 AAAACGGCCGCGCTCACCCCGCTGTCG
guideRna109rvT7sense TAGGACAGCGGGGTGAGCGCGGCC
guideRna109rvT7antisense AAACGGCCGCGCTCACCCCGCTGT
guideRNA109rvT7crTarget GAAATTAATACGACTCACTATAGACAGCGGGGTGAGCGCGGCCGTTTTAGAGCTAGAAATAGCAAG
guideRNAallT7common AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC
gN19-gN20-guideRNA109rvU6senseMLM3636 ACACCGCAGCGGGGTGAGCGCGGCCG
gN19-gN20-guideRNA109rvU6antisenseMLM3636 AAAACGGCCGCGCTCACCCCGCTGCG

PCR to amplify the on-target site

Use these primers to amplify a genomic fragment around the on-target site:
OntargetGuideRna109rvLeft TGCGGTTCAAGCACAGGTAA Tm 60.179
OntargetGuideRna109rvRight CTGTTCAGTTTTCGACCCGC Tm 59.765

Genome fragment with validation primers (underlined) and guide sequence (yellow)

Maximum amplicon length:     Primer Tm:

Your guide sequence is on the reverse strand relative to the genome sequence, so it is reverse complemented in the sequence below.

Genomic sequence chr5:115238103-115238126 including primers, genomic forward strand:
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG


TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Sequence length: 351

Method: Primer3.2 with default settings, target length 250-400 bp,


Restriction Sites for PCR product validation

Cas9 induces mutations, usually 3bp 5' of the PAM site. If a mutation is induced, then it is very likely that one of the following enzymes no longer cuts your PCR product amplified from the mutant sequence. For each restriction enzyme, the guide sequence with the restriction site underlined is shown below.

EnzymePatternGuide with Restriction SiteSuppliers
BshFI/BsuRI/HaeIII/BspANI/AoxI/BsnIGGCC ACAGCGGGGTGAGCGCGGCCCGG EURx, Life Technologies, Minotech, Molecular Biology Resources, NEB, Nippon Gene, Promega, Roche, SibEnzyme, Sigma, Takara, Toyobo, Vivantis
BmeT110I/Eco88I/AvaI/BsiHKCI/Ama87I/BsoBICYCGRG ACAGCGGGGTGAGCGCGGCCCGG EURx, Life Technologies, Molecular Biology Resources, NEB, Nippon Gene, SibEnzyme, Takara, Vivantis
TauIGCSGC ACAGCGGGGTGAGCGCGGCCCGG Life Technologies
MwoI/HpyF10VI/BstMWIGCNNNNNNNGC ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, NEB, SibEnzyme
MspI/HpaII/HapII/BsiSICCGG ACAGCGGGGTGAGCGCGGCCCGG EURx, Life Technologies, Minotech, Molecular Biology Resources, NEB, Nippon Gene, Promega, SibEnzyme, Sigma, SinaClon BioScience, Takara, Vivantis
BseDI/BsaJI/BssECICCNNGG ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, NEB, SibEnzyme
PspPI/BmgT120I/Sau96I/Cfr13I/AspS9IGGNCC ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, Minotech, NEB, Nippon Gene, SibEnzyme, Takara, Vivantis
NciI/BpuMI/AsuC2I/BcnICCSGG ACAGCGGGGTGAGCGCGGCCCGG, ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, NEB, Nippon Gene, Promega, SibEnzyme, Takara, Vivantis
LpnPICCDG ACAGCGGGGTGAGCGCGGCCCGG NEB
StyD4I/Bme1390I/BstSCI/BmrFI/ScrFI/MspR9ICCNGG ACAGCGGGGTGAGCGCGGCCCGG, ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, NEB, Nippon Gene, SibEnzyme, Vivantis
Cfr9I/SmaI/TspMI/XmaICCCGGG ACAGCGGGGTGAGCGCGGCCCGG EURx, Life Technologies, Minotech, Molecular Biology Resources, NEB, Nippon Gene, Promega, Roche, SibEnzyme, Sigma, SinaClon BioScience, Takara, Toyobo, Vivantis
Fsp4HI/PkrI/Fnu4HI/BlsI/BisI/GluI/SatIGCNGC ACAGCGGGGTGAGCGCGGCCCGG Life Technologies, NEB, SibEnzyme

All restriction enzyme sites on the amplicon sequence

Restriction sites are shown in yellow, the guide sequence is highlighted in bold. Use this schema to check if the sites are unique enough to give separate bands on a gel:

Enzyme: BshFI/BsuRI/HaeIII/BspANI/AoxI/BsnI, Site: GGCC, Restriction fragment lengths: 53bp, 129bp, 82bp, 1bp, 71bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: BmeT110I/Eco88I/AvaI/BsiHKCI/Ama87I/BsoBI, Site: CYCGRG, Restriction fragment lengths: 49bp, 118bp, 173bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: TauI, Site: GCSGC, Restriction fragment lengths: 54bp, 15bp, 117bp, -2bp, 125bp, 18bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: MwoI/HpyF10VI/BstMWI, Site: GCNNNNNNNGC, Restriction fragment lengths: 1bp, 13bp, 0bp, -2bp, 3bp, -2bp, 40bp, 10bp, -7bp, 32bp, 8bp, 17bp, 3bp, -6bp, 88bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGC
AGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: MspI/HpaII/HapII/BsiSI, Site: CCGG, Restriction fragment lengths: 50bp, 120bp, 97bp, 73bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: BseDI/BsaJI/BssECI, Site: CCNNGG, Restriction fragment lengths: 49bp, 49bp, 63bp, 30bp, 48bp, 83bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: PspPI/BmgT120I/Sau96I/Cfr13I/AspS9I, Site: GGNCC, Restriction fragment lengths: 52bp, 99bp, 24bp, 82bp, 75bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
C
GCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: NciI/BpuMI/AsuC2I/BcnI, Site: CCSGG, Restriction fragment lengths: 49bp, -4bp, 118bp, -4bp, 95bp, 73bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: LpnPI, Site: CCDG, Restriction fragment lengths: 50bp, 75bp, 41bp, 25bp, 56bp, 8bp, 0bp, 69bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: StyD4I/Bme1390I/BstSCI/BmrFI/ScrFI/MspR9I, Site: CCNGG, Restriction fragment lengths: 49bp, -4bp, 74bp, 39bp, -4bp, 84bp, 6bp, 73bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: Cfr9I/SmaI/TspMI/XmaI, Site: CCCGGG, Restriction fragment lengths: 49bp, 118bp, 173bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG

Enzyme: Fsp4HI/PkrI/Fnu4HI/BlsI/BisI/GluI/SatI, Site: GCNGC, Restriction fragment lengths: 20bp, 29bp, 15bp, 37bp, 75bp, -2bp, 30bp, 90bp, 18bp
TGCGGTTCAAGCACAGGTAAGCAGCGCTGTCCCCGCGCCGTCCCCGCGACCCGGGCCGCGCTCACCCCGCTGTCGCCGCA
GGTACCTTCTGTGCGAGCTGGTGTCCGAGGACGCGCGCTGCCGTTTGAGCCTGGACGACCGCGTGCTGGGCGGGCTGGTC
CGCGACACGATCGCCCGGGTGCACGGGGCCTTCGGCGCCGCCGCCTGCTCCGTGGGCTTTGCAGGTACGAGGGCGCTGCG
GATGCAGTGCGGGGCGCGCTTTGCCAGGGCGAGGCCCGGCCAGTGTGTCGCGTTTTGTACGATAGTGGAGGGTTCTAGAA
AATCGGAGTGCGGCGGGTCGAAAACTGAACAG


PCR to amplify off-target sites

Primers for all off-targets can be downloaded from the Off-target PCR page.

BETA: Guide mutations to minimize on-target activity

Click here to list mutated guides sorted by off-targetactivity

Saturating mutagenesis using all guides

Oligonucleotides of all guides for pooled cloning into a lentiviral vector can be downloaded from the Saturating mutagenesis page.


Version 5.01 - Documentation  - Contact us - Downloads/local installation - Citation - License
CRISPR/Cas9 Guide Designer for chordate vertebrate ecdysozoans lophotrochozoans protostomes spongi corals plants butterflies metazoans genomes fruitflies insects nematodes mammals.